Nexentis Technologies Inc.
Close on Oct 19, 2026
- Market cap
- $522.65K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Nexentis Technologies has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Nexentis Technologies filed with the SEC
Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Statements of Changes in Shareholder’s Equity (Deficit)
Other events · EX-99.1 to Form 8-K/A
Interim Statements of Changes in Shareholder’s Equity (Deficit)
Other events · EX-99.2 to Form 8-K/A
PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
Other events · EX-99.3 to Form 8-K/A
Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Acquisition or disposition completed · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Regains Compliance with Nasdaq Minimum Bid Price Requirement
Listing notice · Other events · EX-99.1 to Form 8-K
Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung
Shareholder vote results · Other events · EX-99.1 to Form 8-K
N2OFF Announces Reverse Stock Split
Other events · EX-99.1 to Form 8-K
Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Save Foods Ltd. (100%) Wins Patent Opposition Filed by ECOLAB in Europe
Regulation FD disclosure · EX-99.1 to Form 8-K
Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Other events · EX-99.1 to Form 8-K
Announces Strategic Initiatives Intended to Maximize Shareholder Value
Material agreement · New financial obligation · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
N2OFF Inc. and Solterra Announce Potential to Increase
Regulation FD disclosure · EX-99.1 to Form 8-K
Inc. Solar PV JV Secures Approval to Connect First PV Solar Project in Germany to the Power Grid of a Regional Energy Provider
Regulation FD disclosure · EX-99.1 to Form 8-K
INC. Entered into an Agreement to Fund up to € 8 million for 50% Rights in Several Solar PV Projects to be Developed by Solterra
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Foods Announces Corporate Rebranding Changes Name to N2OFF Inc. to Reflect Core Values of its Business
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Foods’ Subsidiary Changes its Name to NTWO OFF Ltd.
Regulation FD disclosure · EX-99.1 to Form 8-K
Foods’ Board of Directors Decide to Distribute Plantify Holdings to Stockholders Later in 2024
Other events · EX-99.1 to Form 8-K
Foods Announces the approval by its stockholders of the Nasdaq 20% Share Issuance under the $USD20 Million Standby Equity Purchase Agreement
Shareholder vote results · Other events · EX-99.1 to Form 8-K
B.C. – September 22, 2023, Save Foods, Inc. (“ Save Foods ” or the “ acquiror ”), of Hapardes
Other events · EX-99.1 to Form 8-K
Foods, Inc. Has Acquired Direct Ownership of 30,004,349 Common Shares of Plantify Foods, Inc.
Other events · EX-99.1 to Form 8-K
Foods, Inc. Announces Signing of Securities Exchange Agreement with Plantify Foods, Inc.
Material agreement · Unregistered share sale · Executive or director change · Other events · EX-99.1 to Form 8-K
Foods Announces Pricing of Public Offering of Common Stock
Material agreement · Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Foods Receives Regulatory Approval from the CDPR to Commence Commercialization in California
Other events · EX-99.1 to Form 8-K